Scholars Central

Research articlePublished 28 Nov 2025

Phosphatidylserine Matrix Enhances Lutein/Zeaxanthin Exposure versus Phosphatidylcholine, Liposome, and MCT Oil in Rats: A 24?Hour Pharmacokinetic Study

Authors: S. Mehkri, K.G. Dinesh, G. Ashok, Krathish Bopanna

Journal of Clinical Trials

Volume 15 · Issue 7 · Pages 1–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Lutein and Zeaxanthin (LZ) support macular function, but oral absorption is limited by intestinal solubilization and uptake; phospholipid environments may improve micellization and enterocyte transport. Objective: To evaluate whether an anionic Phosphatidylserine (PS) matrix enhances single-dose LZ exposure compared to Phosphatidylcholine (PC), a reconstituted liposomal powder, and Medium-Chain Triglyceride (MCT) oil in rats. Methods: Male Sprague-Dawley rats (n=6 per group) received oral gavage of dose-matched lutein (10 mg/kg) in four matrices (MCT, MCT+PC, MCT+PS, liposome); serial plasma samples (0-24 h) were analysed using validated LC-MS/MS (calibration 5-250 ng/mL). Noncompartmental pharmacokinetics were calculated; group differences in Cmax and AUC₀–t were evaluated via one-way ANOVA with Dunnett contrasts versus MCT. Results: LZ exposure followed the order PS > PC ≈ liposome > MCT. Cmax (ng/mL, mean ± SD): 52.54 ± 0.70 (MCT), 60.45 ± 1.24 (PC), 69.63 ± 0.78 (PS), 62.39 ± 1.12 (liposome). AUC₀–t (ng·h/mL): 494.51 ± 13.70 (MCT), 596.37 ± 30.29 (PC), 620.23 ± 16.41 (PS), 536.70 ± 18.42 (liposome). Dunnett vs MCT: PS p<0.001; PC and liposome p<0.01. T_max was approximately 2 hours for PS/PC versus about 3 hours for MCT/liposome; half-life was similar (~7.7-8.3 hours). Conclusions: Anionic PS oils increase LZ exposure and bioavailability more effectively than PC or liposomal powder at equal doses, without altering elimination.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Trials
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “S. Mehkri”
  • BylineArticles whose byline prints “K.G. Dinesh”
  • BylineArticles whose byline prints “G. Ashok”
  • BylineArticles whose byline prints “Krathish Bopanna”